14.63
-0.13 (-0.88%)
| Penutupan Terdahulu | 14.76 |
| Buka | 14.74 |
| Jumlah Dagangan | 753,892 |
| Purata Dagangan (3B) | 2,205,729 |
| Modal Pasaran | 1,493,913,216 |
| Harga / Buku (P/B) | 11.74 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 11 Aug 2025 |
| EPS Cair (TTM) | -9.25 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 13.68% |
| Nisbah Semasa (MRQ) | 2.33 |
| Aliran Tunai Operasi (OCF TTM) | -644.94 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -394.10 M |
| Pulangan Atas Aset (ROA TTM) | -129.99% |
| Pulangan Atas Ekuiti (ROE TTM) | -316.82% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menurun |
| Biotechnology (Global) | Bercampur | Menurun | |
| Stok | Biohaven Ltd. | Menurun | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | 4.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 4.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 2.0 |
| Purata | 3.25 |
|
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. Its products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 11.96% |
| % Dimiliki oleh Institusi | 90.75% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Suvretta Capital Management, Llc | 31 Dec 2024 | 5,620,271 |
| Bellevue Group Ag | 31 Dec 2024 | 2,040,853 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 60.00 (BTIG, 310.12%) | Beli |
| Median | 52.00 (255.43%) | |
| Rendah | 30.00 (HC Wainwright & Co., 105.06%) | Beli |
| Purata | 50.00 (241.76%) | |
| Jumlah | 7 Beli | |
| Harga Purata @ Panggilan | 13.86 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| BTIG | 19 Aug 2025 | 60.00 (310.12%) | Beli | 15.25 |
| B of A Securities | 12 Aug 2025 | 49.00 (234.93%) | Beli | 13.47 |
| Baird | 12 Aug 2025 | 52.00 (255.43%) | Beli | 13.47 |
| HC Wainwright & Co. | 12 Aug 2025 | 30.00 (105.06%) | Beli | 13.47 |
| Leerink Partners | 12 Aug 2025 | 50.00 (241.76%) | Beli | 13.47 |
| Morgan Stanley | 12 Aug 2025 | 54.00 (269.10%) | Beli | 13.47 |
| JP Morgan | 18 Jun 2025 | 55.00 (275.94%) | Beli | 14.39 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |